EcoDrugPlus

Complement Factor D

Ensembl ID : ENSELUG00000024158
Gene Symbol: LOC105015868
3 Cross references
134 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSELUG00000012482
Gene Symbol: CRHR1
1 Cross references
203 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSELUG00000010020
Gene Symbol: CCND1
3 Cross references
133 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSELUG00000005428
Gene Symbol: CDK1
2 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSELUG00000020932
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSELUG00000020584
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSELUG00000022250
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSELUG00000020987
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSELUG00000010983
Gene Symbol: CDK7
1 Cross references
219 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSELUG00000019692
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSELUG00000026002
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSELUG00000030887
Gene Symbol: CDA
3 Cross references
163 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).